Find previous editions of the BiotechDueDiligence Journal Watch.
Free Review on molecular/cytogenetic features of AML and current treatment paradigms http://t.co/zL7scMKvzb via @JAMAOnc
— Garrett Rhyasen, PhD (@MrStemCell) May 2, 2015
this newest issue packed with top-tier articles, nearly all #openaccess
I'm starting with #CD226 & #TIGIT #ImmTx https://t.co/TGk3Z28BI8
— Paul D. Rennert (@PDRennert) May 1, 2015
@JohnTuckerPhD @cardiobrief I love this figure
http://t.co/ECrTUvSxsQ pic.twitter.com/0Is7Nko9R9
— Ethan Weiss (@ethanjweiss) April 30, 2015
Good Read --> Statistics: P values are just the tip of the iceberg
http://t.co/4KRYJKi0VM
http://t.co/hYAEtHqLCn pic.twitter.com/YkIbiaXYbm
— Andy Biotech (@AndyBiotech) April 29, 2015
Holy moly. Germline editing got real https://t.co/HTKuSvVXw7
— Michael Koeris (@mkoeris) April 22, 2015
Accompanying editorial. http://t.co/w9EvJHiDGZ https://t.co/rrvIQ2Lrjz
— PropThink (@PropThinker) April 21, 2015
How dogs stole our hearts?
http://t.co/c9doRgsPQ5
http://t.co/gyh5eSHaF4
http://t.co/9weStKduZe
CC @LifeSciencesMkt pic.twitter.com/k5Fdw8wzEM
— Andy Biotech (@AndyBiotech) April 17, 2015
Randomized Trial of Primary PCI with or w/out Routine Manual Thrombectomy. Cautionary tail of perils of small trials http://t.co/1eaSuWcH3t
— David Grainger (@sciencescanner) April 9, 2015
Some weekend reading, articles are free ; ) http://t.co/YP3phSHSAq
http://t.co/hk7pFGL35l
http://t.co/yAAauOB1nP
— Joe Prete, Pharm.D. (@JoeP450) April 4, 2015
Special Issue of STM on #ImmunoTherapy This wk
http://t.co/G9hRdpXoaw
#Cancer
#Lupus
#arthritis
#transplant
#Allergy pic.twitter.com/OurpmfWo1k
— Andy Biotech (@AndyBiotech) March 25, 2015